Meet the Preliminary Dogs of the Dow for 2018
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
These are four quality companies that should continue to do well in 2018. Investors to want to buy the shares and put them in their accounts for a long time.
24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors. It has been almost amazing to see just how many price targets…
UnitedHealth, J&J, Nike, and Verizon lifted the DJIA on Tuesday.
Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.
Earnings season is just kicking off for the third quarter with markets pushing all-time highs. Seven Dow stocks reporting this week, and nearly half of them are reporting on Tuesday.
24/7 Wall St. has put together a preview of GE, Verizon and other the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Walmart, Johnson & Johnson, McDonald's, and Visa pushed the DJIA higher on Wednesday.
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.
These five new additions to Deutsche Bank’s Conviction List all make good sense for growth portfolios now.
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and…
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean and Under Armour.